Loading percentile ranking…
Loading percentile ranking…
Loading deep stats…
Loading deep stats…
Under which conditions does this player change? Rates from Σ/Σ.
Difference vs season baseline (per game / rate). Sample size shown.
| Split | G | MIN | PTS | REB | AST | FG% | 3P% | TS% | TOV |
|---|---|---|---|---|---|---|---|---|---|
| Home | 41 | 1396 | +0.1 | +0.1 | +0.0 | -1.3pp | -0.7pp | -0.6pp | +0.0 |
| Away | 39 | 1334 | -0.1 | -0.1 | -0.0 | +1.3pp | +0.7pp | +0.7pp | -0.0 |
| Wins | 30 | 1045 | +1.4 | +0.4 | +0.3 | +1.2pp | -0.3pp | +2.0pp | +0.0 |
| Losses | 50 | 1685 | -0.9 | -0.2 | -0.2 | -0.7pp | +0.2pp | -1.3pp | -0.0 |
| Primary splits | G | MIN | PTS | REB | AST | FG% | 3P% | FT% | TS% | eFG% | TOV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Home | 41 | 1396 | 18.2 | 4.9 | 1.4 | 44.9% | 31.3% | 83.2% | 52.8% | 47.7% | 1.2 |
| Away | 39 | 1334 | 18.0 | 4.7 | 1.3 | 47.5% | 32.7% | 89.4% | 54.1% | 50.5% | 1.2 |
| Wins | 30 | 1045 | 19.5 | 5.2 | 1.7 | 47.3% | 31.7% | 86.4% | 55.4% | 50.1% | 1.2 |
How did performance evolve during the season?
| By month | G | MIN | PTS | REB | AST | FG% | 3P% | FT% | TS% | eFG% | TOV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-10 | 10 | 258 | 10.8 | 4.2 | 0.6 | 37.0% | 27.6% | 95.2% | 46.1% | 40.7% | 0.8 |
| 2016-11 | 12 | 444 | 20.8 | 5.5 | 1.2 | 46.0% | 23.5% | 84.3% | 52.4% | 47.9% | 1.5 |
| 2016-12 | 16 | 556 | 20.4 | 5.2 | 1.5 | 48.0% | 36.2% | 86.5% | 54.7% | 51.1% | 1.4 |
PTS per game vs season average · sorted best → worst · G shown
| Opponent | G | MIN | PTS | REB | AST | FG% | 3P% | FT% | TS% | eFG% | TOV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HOU | 5 | 169 | 18.0 | 4.0 | 0.6 | 43.1% | 33.3% | 100.0% | 54.5% | 45.8% | 1.0 |
| SA | 4 | 135 | 16.0 | 3.8 | 1.3 | 47.5% | 33.3% | 62.5% | 51.2% | 50.0% | 1.5 |
| LAC | 4 | 141 | 20.5 | 4.0 | 1.3 | 52.2% | 30.8% | 85.7% | 56.9% | 55.1% |
Conservation: Home+Away, Wins+Losses, and Starter+Bench each equal the season game universe when those fields are complete.
| Losses |
| 50 |
| 1685 |
| 17.2 |
| 4.5 |
| 1.2 |
| 45.5% |
| 32.1% |
| 84.8% |
| 52.1% |
| 48.4% |
| 1.2 |
| 2017-01 |
| 13 |
| 455 |
| 20.6 |
| 4.8 |
| 2.0 |
| 49.3% |
| 34.2% |
| 82.2% |
| 55.6% |
| 52.3% |
| 1.0 |
| 2017-02 | 10 | 360 | 18.4 | 4.9 | 1.4 | 48.4% | 28.6% | 75.0% | 53.8% | 51.0% | 1.2 |
| 2017-03 | 14 | 499 | 17.1 | 4.9 | 1.5 | 42.7% | 34.4% | 88.3% | 51.6% | 45.4% | 1.3 |
| 2017-04 | 5 | 158 | 14.6 | 2.6 | 1.0 | 50.0% | 42.9% | 93.8% | 61.8% | 55.8% | 1.4 |
| 2.3 |
| OKC | 4 | 128 | 15.5 | 2.8 | 1.3 | 39.7% | 27.3% | 86.7% | 48.0% | 42.2% | 0.3 |
| PHX | 4 | 131 | 17.8 | 5.8 | 2.0 | 49.1% | 20.0% | 85.7% | 57.0% | 50.0% | 0.5 |
| LAL | 4 | 138 | 17.0 | 5.5 | 2.5 | 42.6% | 18.2% | 82.4% | 49.6% | 44.3% | 1.8 |
| UTAH | 4 | 156 | 21.3 | 3.5 | 1.5 | 49.3% | 36.4% | 73.3% | 54.8% | 52.1% | 1.3 |
| POR | 4 | 147 | 21.0 | 7.3 | 0.5 | 47.2% | 25.0% | 81.3% | 53.1% | 49.3% | 1.0 |
| DEN | 4 | 126 | 14.3 | 3.0 | 1.0 | 54.3% | 14.3% | 75.0% | 57.6% | 55.4% | 1.3 |
| SAC | 3 | 90 | 12.3 | 5.0 | 1.3 | 34.1% | 25.0% | 70.0% | 40.7% | 36.6% | 1.7 |
| MIL | 3 | 106 | 23.7 | 5.7 | 1.0 | 48.1% | 38.5% | 94.1% | 59.7% | 52.9% | 2.0 |
| MEM | 3 | 109 | 13.7 | 4.7 | 0.7 | 35.7% | 16.7% | 100.0% | 44.2% | 36.9% | 1.3 |
| GS | 3 | 96 | 18.3 | 5.0 | 1.3 | 43.8% | 36.4% | 90.0% | 52.5% | 47.9% | 0.3 |
| MIN | 3 | 103 | 21.0 | 3.7 | 0.7 | 50.0% | 38.5% | 50.0% | 54.5% | 54.5% | 1.7 |
| CHA | 3 | 93 | 16.3 | 6.0 | 1.7 | 37.3% | 40.0% | 100.0% | 45.3% | 41.2% | 0.3 |
| TOR | 2 | 73 | 20.5 | 4.5 | 1.5 | 45.5% | 25.0% | 100.0% | 54.8% | 47.0% | 0.0 |
| BKN | 2 | 73 | 20.0 | 6.0 | 1.0 | 50.0% | 75.0% | 100.0% | 60.5% | 55.0% | 2.5 |
| PHI | 2 | 56 | 9.5 | 6.0 | 1.0 | 40.0% | 25.0% | 100.0% | 45.5% | 42.5% | 0.5 |
| WSH | 2 | 75 | 24.0 | 8.0 | 3.5 | 52.9% | 50.0% | 81.8% | 61.8% | 57.4% | 2.5 |
| ATL | 2 | 68 | 23.0 | 4.0 | 2.0 | 52.9% | 62.5% | 83.3% | 62.8% | 60.3% | 1.5 |
| MIA | 2 | 70 | 19.5 | 5.5 | 1.5 | 50.0% | 0.0% | 100.0% | 55.6% | 50.0% | 0.5 |
| DET | 2 | 74 | 17.5 | 5.0 | 1.5 | 47.1% | 11.1% | 100.0% | 50.2% | 48.5% | 1.0 |
| BOS | 2 | 76 | 23.5 | 2.5 | 2.0 | 47.5% | 40.0% | 70.0% | 52.9% | 50.0% | 2.0 |
| ORL | 2 | 69 | 9.5 | 5.0 | 2.5 | 26.9% | 25.0% | 80.0% | 33.7% | 28.8% | 0.5 |
| CLE | 2 | 67 | 18.0 | 7.0 | 1.5 | 51.7% | 0.0% | 85.7% | 56.1% | 51.7% | 1.5 |
| NY | 2 | 72 | 21.5 | 4.0 | 1.0 | 50.0% | 0.0% | 84.6% | 57.0% | 50.0% | 2.5 |
| IND | 2 | 71 | 22.0 | 8.0 | 1.0 | 58.1% | 66.7% | 50.0% | 67.2% | 67.7% | 1.0 |
| NO | 1 | 18 | 12.0 | 0.0 | 2.0 | 37.5% | 50.0% | 100.0% | 61.5% | 50.0% | 0.0 |